Cytogenetic manifestations of multiple myeloma heterogeneity (Q34360608)

1 August 2017

Cytogenetic manifestations of multiple myeloma heterogeneity (English)

1 reference

1 August 2017

1 reference

1 reference

Dimitra Pantou

1

1 reference

1 August 2017

Helen Rizou

2

1 reference

1 August 2017

Haroula Tsarouha

3

1 reference

1 August 2017

Anastasia Pouli

4

1 reference

1 August 2017

Kostas Papanastasiou

5

1 reference

1 August 2017

Marina Stamatellou

6

1 reference

1 August 2017

Theoni Trangas

7

1 reference

1 August 2017

Nikos Pandis

8

1 reference

1 August 2017

Georgia Bardi

9

1 reference

1 August 2017

1 January 2005

1 reference

Genes, Chromosomes and Cancer

1 August 2017

1 reference

1 August 2017

42

1 reference

1 August 2017

44-57

1 reference

1 August 2017

1

1 reference

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

1 August 2017

1 reference

7 January 2021

Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features

1 reference

7 January 2021

Treatment of multiple myeloma

1 reference

7 January 2021

1 reference

7 January 2021

Chromosome translocations in multiple myeloma

1 reference

7 January 2021

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

1 reference

7 January 2021

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

1 reference

7 January 2021

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

1 reference

7 January 2021

Clinical and biologic implications of recurrent genomic aberrations in myeloma

1 reference

7 January 2021

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

1 reference

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

7 January 2021

Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation

1 reference

7 January 2021

A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences

1 reference

7 January 2021

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia

1 reference

7 January 2021

Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma

1 reference

7 January 2021

Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling

1 reference

7 January 2021

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

7 January 2021

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20114

1 reference

1 August 2017

1 reference